6533b81ffe1ef96bd12773e9

RESEARCH PRODUCT

Phosphoproteome Profiling Reveals Multifunctional Protein NPM1 as part of the Irradiation Response of Tumor Cells

Juergen BriegerNadine WiesmannRita GieringerFranz H. Grus

subject

0301 basic medicineCancer ResearchProgrammed cell deathOriginal articleNucleoplasmCell cycle checkpointChemistryNucleolusmedicine.disease_causelcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282Cell biologyDephosphorylation03 medical and health sciences030104 developmental biology0302 clinical medicineOncologyCytoplasm030220 oncology & carcinogenesismedicineCarcinogenesisIntracellular

description

To fight resistances to radiotherapy, the understanding of escape mechanisms of tumor cells is crucial. The aim of this study was to identify phosphoproteins that are regulated upon irradiation. The comparative analysis of the phosphoproteome before and after irradiation brought nucleophosmin (NPM1) into focus as a versatile phosphoprotein that has already been associated with tumorigenesis. We could show that knockdown of NPM1 significantly reduces tumor cell survival after irradiation. NPM1 is dephosphorylated stepwise within 1 hour after irradiation at two of its major phosphorylation sites: threonine-199 and threonine-234/237. This dephosphorylation is not the result of a fast cell cycle arrest, and we found a heterogenous intracellular distribution of NPM1 between the nucleoli, the nucleoplasm, and the cytoplasm after irradiation. We hypothesize that the dephosphorylation of NPM1 at threonine-199 and threonine-234/237 is part of the immediate response to irradiation and of importance for tumor cell survival. These findings could make NPM1 an attractive pharmaceutical target to radiosensitize tumor cells and improve the outcome of radiotherapy by inhibiting the pathways that help tumor cells to escape cell death after gamma irradiation.

10.1016/j.tranon.2018.10.015http://www.sciencedirect.com/science/article/pii/S1936523318304959